Funded Tech Companies

iTeos Therapeutics

Wondering who invested in iTeos Therapeutics? SRIW, HBM Healthcare Investments and Curative Ventures joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

iTeos Therapeutics (Nasdaq: ITOS) is a next-generation immuno-oncology company developing innovative anti-cancer agents to fulfil the promise of immunotherapy by targeting the tumor microenvironment to improve the lives of people living with cancer. The Company is targeting two key pathways by which cancer cells suppress the immune system.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/24/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Michel Detheux

        

Chief Medical Officer

Joanne Lager

        

Chief Operating Officer

Matthew Call

        

VP - General Counsel

Gregory Sieczkiewicz

        

Company Investors

• SRIW
• HBM Healthcare Investments
• Curative Ventures
• Invus
• Boxer Capital (Aaron Davis)
• 6 Dimensions Capital
• MPM Capital
• RTW Investments
• RA Capital (Derek DiRocco)
• Fund+
• Janus Henderson Investors
• SFPI-FPIM
• VIVES Inter-University Fund

Browse more funded tech companies:

Itential | Iterable

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary